#5e2d92_SMALL_Nov-Dec 2024 DRA Journal Cover

From myth-busting photobiomodulation therapy to showcasing advanced aesthetic cases, this issue delivers practical insights for modern dental practice. Explore evidence-based techniques in implant and veneer rehabilitation, essential guidance on monkeypox protocols, and strategies for enhanced patient communication.

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

FDA grants Videa Perio Assist 510(k) clearance

VideaHealth’s AI-powered interproximal bone level measurement tool for periodontal disease assessment, Videa Perio Assist, has received 510(k) clearance from the US Food and Drug Administration (FDA). 

“Videa Perio Assist has been a game-changer for our hygienists and dentists as it helps them more effectively identify signs of periodontal disease,” said Marlene Kacy, Director of Hygiene at 42 North Dental. 

“VideaHealth not only empowers our team to make better treatment recommendations, but also its intuitive visualizations make it very easy for us to educate patients and explain our findings to them.”

Measures interproximal bone level changes

Videa Perio Assist allows dentists and hygienists to measure interproximal bone level changes over time for patients aged 12 and above, resulting in faster and more accurate treatment recommendations and improved patient outcomes, according to VideaHealth. 

“Videa Perio Assist enables a more comprehensive and proactive approach to assessing interproximal RBL and monitoring periodontal disease,” said Florian Hillen, founder and CEO of VideaHealth.

In addition to its recent 510(k) clearance, VideaHealth also obtained a US patent for its dental AI image recognition technology. Patent no. 11,553,874 covers dental image feature detection powered by machine learning that helps dentists detect dental diseases on images and matches those findings to patient records.

Early identification of systemic diseases

Nearly 50% of adults over the age of 30 have periodontal disease, according to the Centers for Disease Control and Prevention. While traditional periodontal probing is a valuable supplement in diagnosing periodontal disease, reader experience or systemic conditions can often affect the accuracy of measurements. 

The use of Videa Perio Assist’s interproximal radiographic bone level (RBL), powered by AI algorithms, allows dental clinicians to supplement and support their periodontal probing findings more quickly and accurately, thereby aiding in the early identification of some systemic diseases. 

“Since our inception, we’ve worked directly with dentists and DSOs [Dental Service Organizations] to understand how AI can elevate care and move the dental industry forward. Periodontal disease has consistently been mentioned as a top concern, in part because of the challenges with interpreting its signs,” said Hillen. 

Videa Perio Assist is part of VideaHealth’s dental AI platform, Videa Assist.

Leading Dental Service Organizations (DSOs) like Heartland Dental and 42 North are already using Videa Assist, which seamlessly integrates with leading practice management systems, including Henry Schein One’s Dentrix, increasing access to thousands of dental practices across the nation.

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.

Leave a Reply

Your email address will not be published. Required fields are marked *